Basic info
Industry
biotechnology research
Sectors
Pharmaceutical
Biotechnology
Pharmacology
Health Care
New drug discovery
Discovery biology
Oncology diseases
Medicinal Chemistry
CMC
Clinical development
Autoimmune diseases
Medical research
Date founded
2013
Funding rounds raised
Total raised
$160M
from 5 investors over 5 rounds
I
InnoCare Pharma 诺诚健华(HKEX: 09969; SSE: 688428) raised undisclosed on February 3, 2021
Investors: Hillhouse Capital Management and Vivo Capital
I
InnoCare Pharma 诺诚健华(HKEX: 09969; SSE: 688428) raised $160M on January 3, 2019
Investors: Loyal Valley Capital and Vivo Capital
I
InnoCare Pharma 诺诚健华(HKEX: 09969; SSE: 688428) raised $55M on February 9, 2018
Investors: Vivo Capital